The ROE (Return on Equity) of Royalty Pharma PLC (RPRX) is 12.37%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 12.37% |
| 2023-12-31 | 17.39% |
| 2022-12-31 | 0.76% |
| 2021-12-31 | 10.73% |
| 2020-12-31 | 20.23% |
| 2019-12-31 | 38.46% |
| 2018-12-31 | 30.70% |